Sire Bioscience Inc. (CNSX:SIRE) entered into a binding letter of intent to acquire Amino Balls Inc. for CAD 0.13 million on July 22, 2020. To effect the transaction, Sire Bioscience expects to issue its 8.8 million common shares upon satisfaction of the closing conditions. These payment shares will be subject to a 12 month escrow provision. The transaction is subject to closing conditions including successful completion of due diligence on Amino Balls. Sire Bioscience Inc. (CNSX:SIRE) cancelled the acquisition of Amino Balls Inc. on June 21, 2021.